Behbahani Ali 4
4 · Black Diamond Therapeutics, Inc. · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
Black Diamond (BDTX) Director Ali Receives 8,961-Share Award
What Happened Behbahani Ali, a non-employee director of Black Diamond Therapeutics, received an award of 8,961 shares of common stock on June 19, 2026. The filing lists a per-share price of $1.66 (based on the June 18, 2026 closing price), for a reported aggregate value of about $14,875. This was an equity award issued under the company's non-employee director compensation policy (shares elected in lieu of cash), which is a routine form of director compensation rather than an open-market purchase or sale.
Key Details
- Transaction date: June 19, 2026; Form 4 filed June 22, 2026 (timely).
- Transaction type: Award/Acquisition (A) — 8,961 shares.
- Price used: $1.66 per share (based on 6/18/2026 closing price).
- Reported aggregate value: $14,875.
- Shares owned after transaction: Not disclosed in the filing.
- Notable footnotes:
- F1: Shares issued under the Issuer's Sixth Amended and Restated Non-Employee Director Compensation Policy; the director elected shares instead of cash.
- F2: Price in the filing is based on the 6/18/2026 closing market price.
- F3: Notes a manager/general partner relationship involving NEA entities and disclaimers of beneficial ownership for securities held by NEA 16 (per filing language).
Context Director awards issued in lieu of cash are common and typically reflect routine compensation, not necessarily a signal of personal trading intent. This transaction is an acquisition (award) rather than a purchase from the market or a sale, so retail investors should treat it as compensation-related insider activity.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-19$1.66/sh+8,961$14,875→ 102,529 total
- 4,448,757(indirect: See Note 3)
Common Stock
[F3]
Footnotes (3)
- [F1]These shares were issued in accordance with the Issuer's Sixth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 18, 2026.
- [F3]The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.